how much of what we believe about 503A actually comes from telehealth threads
how much of what we believe about 503A actually comes from telehealth threads. I am not trying to be the "source?" guy. I would just like a source.
Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot.
Asked for the beyond-use date basis and got a real answer with a stability reference attached. Not universal, apparently.
Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.
Tell me where this is wrong. That is the useful part of posting it.
best — the order this archive was captured in
Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label.
a telehealth intake that asks nothing has told you what it is
503A or 503B — do you know which?
Compounded preparations are not approved products and carry no bioequivalence claim. That is a statement about regulatory category, not about quality.
What did the intake actually ask you?
Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material. Ask which you are being shown.
Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material.
Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.
Not convinced. You are comparing a compounded concentration with a branded one and assuming they match.